Home › Funds › Tejara Capital Ltd › MRVI
Tejara Capital Ltd position in MRVI
MARAVAI LIFESCIENCES HLDGS I · Health Care
Tejara Capital Ltd reported holding 1,595,345 shares of MRVI (MARAVAI LIFESCIENCES HLDGS I) in its Q2 2026 13F filing — a position valued at US$10.0M, representing 4.09% of its reported portfolio and ranking #5 among its reported holdings. Tejara Capital Ltd has disclosed MRVI holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Tejara Capital Ltd's MRVI position evolved
Tejara Capital Ltd first disclosed a stake in MRVI in Q1 2025 at 542,549 shares (US$1.2M). The position peaked in Q2 2026 at 1,595,345 shares, worth US$10.0M. Across 6 filings, Tejara Capital Ltd increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,595,345 shares valued at US$10.0M — a reduction of -1,899,842 shares quarter over quarter.. Notable position changes include a 258% increase in Q2 2025 (shares rose 19% over the following quarter), a 26% increase in Q3 2025 (shares rose 13% over the following quarter), a 54% trim in Q2 2026 (shares rose 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 542.55K | $1.20M | New |
| Q2 2025 | 1.94M | $4.68M | Add |
| Q3 2025 | 2.45M | $7.04M | Add |
| Q4 2025 | 3.02M | $9.82M | Add |
| Q1 2026 | 3.50M | $9.89M | Add |
| Q2 2026 | 1.60M | $9.95M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRVI and 13F data
MRVI (MARAVAI LIFESCIENCES HLDGS I) is a Health Care company. 35 other funds we track also report a position in MRVI — the largest reported positions include GTCR LLC (US$125.7M), BRAIDWELL LP (US$54.3M), 12 West Capital Management LP (US$44.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRVI
- GTCR LLC 20.15M sh · $125.74M · Q2 2026
- BRAIDWELL LP 8.70M sh · $54.31M · Q2 2026
- 12 West Capital Management LP 7.06M sh · $44.06M · Q2 2026
- Ophir Asset Management Pty Ltd 4.83M sh · $30.12M · Q2 2026
- Monaco Asset Management SAM 2.23M sh · $13.92M · Q2 2026
- Philosophy Capital Management LLC 1.90M sh · $11.86M · Q2 2026
- GENERAL AMERICAN INVESTORS CO INC 1.72M sh · $10.71M · Q2 2026
More on Tejara Capital Ltd
FAQ
How long has Tejara Capital Ltd held MRVI?
Tejara Capital Ltd has disclosed MRVI holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Tejara Capital Ltd's current position in MRVI?
As of Q2 2026, Tejara Capital Ltd holds 1.60M shares of MRVI (MARAVAI LIFESCIENCES HLDGS I), valued at $9.95M, representing 4.09% of its reported portfolio and ranking #5.
Has Tejara Capital Ltd been buying or selling MRVI?
In the latest 13F filing (Q2 2026), Tejara Capital Ltd reduced its position in MRVI. The position peaked in Q2 2026 at 1.60M shares.
Which other funds hold MRVI?
Other major institutional holders of MRVI include GTCR LLC, BRAIDWELL LP, 12 West Capital Management LP, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.